NFKB1 and obesity due to melanocortin 4 receptor deficiency: Genistein is also reported to be effective against obesity during menopause, as its administration suppresses estrogen-deficiency-induced obesity and hepatic lipogenesis by reducing NF-κB activity in an ovariectomized and high-fat diet rat model [48].